GRS Home

The Growth Hormone Research Society



The 10th International Congress of the Growth Hormone Research Society May10-11, 2024 - Stockholm, Sweden

Date and time
Friday 10 - Saturday 11 May 2024. This event will start at approximately 09:00 on Friday and will finish in time for delegates to attend the ECE 2024 Opening Ceremony.

ECE 2024 venues - Stockholmsmässan (, Room TBC

The meeting will provide an update on basic, translational and clinical research in the field of growth hormone related diseases. The format includes plenaries from leading experts in the field, and abstract based oral and poster sessions.
Follow this link for the program

Submission of Abstracts
Abstracts for this Congress must be submitted by email to the Growth Hormone Research Society (GRS): Guidelines for preparation and submission of abstracts can be found here. Abstract submission deadline for the GRS congress is Friday 1 March 2024. Notification to authors of abstract acceptance/rejection - Mid-March 2024.

GRS and ESE encourage that abstracts submitted to the GRS congress are also submitted to ECE 2024 and published in Endocrine Abstracts. Note that abstract submission deadline for ECE is Monday 22 January 2024. For more details about submission of abstracts to ECE 2024 please refer to

NB - You must be registered for the corresponding Congresses in order to present or be published at either meeting.

Delegate fee (GRS congress only)
In-person = 100 Euro
In-person (in-training, nurse, Early Career) = 50 Euro

NB - there is not an option to attend this congress online. The registration fees shown here do not include registration for ECE2024.

Travel grants
More than 50 travel grants are available from GRS for early career attendees who present an abstract.
Follow this link for details

Registration details
You must register for this event through your ECE 2024 registration (you do not have to attend ECE 2024, but your registration will only be valid for the Pre-Congress Course).
Follow this link to register

For further information, please contact the ECE 2024 Congress team on or send an email to GRS at

GH and GHR dimer

find us on facebook


To promote scientific research and clinical advancement in the fields of growth hormone (GH) and insulin-like growth factors (IGFs)


The recent virtual workshop on “Safety of GH treatment in cancer survivors” successfully held in 2021 with over 50 participants. A review paper concerning this meeting was published prior to the meeting (Pituitary. 2021 Oct;24(5):810-827). The outcome of the workshop resulted in a manuscript that has been published: Safety of Growth Hormone Replacement in Survivors of Cancer and Intracranial and Pituitary Tumours: A Consensus Statement. Eur J Endocrinol. 2022 Apr 21;186(6):35-52. doi: 10.1530/EJE-21-1186. 2022 Online.

Potential Up-coming Workshop Topics:
Update on diagnosis of GHD
Genetics of short stature
Transition of GHD patients

Suggestions are welcome!



Consensus Statements


Honorary Members


hGH Indications